| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.08 |